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estimating incidence by age and sex, mother-to-child
transmission, HIV progression in children and
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ABSTRACT
Background The Spectrum program is used to estimate
key HIV indicators from the trends in incidence and
prevalence estimated by the Estimation and Projection
Package or the Workbook. These indicators include the
number of people living with HIV, new infections, AIDS
deaths, AIDS orphans, the number of adults and children
needing treatment, the need for prevention of mother-to-
child transmission and the impact of antiretroviral
treatment on survival. The UNAIDS Reference Group on
Estimates, Models and Projections regularly reviews new
data and information needs, and recommends updates to
the methodology and assumptions used in Spectrum.
Methods The latest update to Spectrum was used in the
2009 round of global estimates. This update contains new
procedures for estimating: the age and sex distribution of
adult incidence, new child infections occurring around
delivery or through breastfeeding, the survival of children
by timing of infection and the number of double orphans.
INTRODUCTION
UNAIDS projections of adult HIV prevalence and
incidence are prepared using the Estimation and
Projection Package (EPP)1 for generalised epidemics
and the Workbook for low-level and concentrated
epidemics.2 The Spectrum projection package is
used to determine the consequences of these
projections, including the number of people living with
HIV by age and sex, new infections, AIDS deaths,
AIDS orphans, the need for treatment and prophylaxis,
and the impact of treatment. Earlier updates to
Spectrum have been described previously.3 4 A full
description of the methodology is provided in the
manual for the AIDSmodule of Spectrum (AIM).5 The
purpose of this paper is to describe the updates to
Spectrummade in the last 2 years and used in the 2009
global estimates of HIV/AIDS.
Spectrum is a modular program used to examine
the consequences of current trends and future
program interventions in reproductive health. The
program and manuals are updated regularly and
available in multiple languages free of charge at
http://www.FuturesInstitute.org/. Model develop-
ment has been funded primarily by USAID,
UNAIDS and the Bill and Melinda Gates Founda-
tion with technical collaboration from UNAIDS,
WHO, Unicef, UN Population Division, US Census
Bureau, UNFPA and other organisations.
Themajor inputs and outputs of theAIDSmodule
of Spectrum are shown in ﬁgure 1. Demographic
projections are based on user inputs or projections
prepared by the United National Population Divi-
sion.6 The projections start with an estimate and
projection of adult incidence, which is combined
with information on the age and sex distribution of
incidence and progression to death to estimate the
number of new adult infections by age and sex. New
infant infections are estimated from prevalence
among pregnant women and the rate of mother-to-
child transmission, which is dependent on infant
feeding practices and the coverage of prophylaxis
with antiretrovirals (ARVs). New infections prog-
ress over time to a symptomatic stage where anti-
retroviral therapy (ART) is needed. Those who
receive ﬁrst- and or second-line ART experience
extended survival. People at any stage are subject to
non-AIDS mortality at the same rates as those who
are not infected. Adult deaths result in orphans.
Several new features have been added to Spec-
trum for the 2009 round of estimates in response to
new data, new treatment guidelines and new needs
by national programmes for planning. There are
new procedures for estimating the age and sex
distribution of adult incidence, new child infections
occurring around delivery or through breastfeeding,
the survival of children by timing of infection, the
effects of HIV infection in fertility and the number
of double orphans.
DISTRIBUTING ADULT INCIDENCE BY AGE AND
SEX
EPP is used to ﬁt a smooth prevalence trend to
surveillance and survey data and to estimate the
associated incidence among adults aged 15e49.
Then, the incidence trend is passed to Spectrum.
Since Spectrum calculations are disaggregated by
age and sex, the adult incidence from EPP also needs
to be converted to age- and sex-speciﬁc incidence.
To do this, we used a mathematical method for
estimating incidence by age from two cross-
sectional measurements of prevalence.7 The model
is based on the assumption that individuals of age
a in the earlier survey will be represented by indi-
viduals aged a+s in the later survey, where s is the
interval between surveys, even though the surveys
do not include the same individuals. The change in
HIV prevalence among individuals aged a in the
ﬁrst survey and a+s in the second survey can then
be attributed to incident infections and AIDS
deaths. By ﬁnding an approximate value for the rate
of AIDS deaths, based on the observed distribution
of survival after infection,8 the HIV incidence for
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that age group can be estimated. This method has been thor-
oughly validated by comparing derived incidence estimates with
actual incidence measurements in cohort studies in Tanzania,
Uganda and Zimbabwe.7 If there is only one survey, the same
procedure can applied, making the additional assumption that
HIV prevalence was constant in the 5 years preceding that
survey. (If prevalence is not constant, the pattern for some age
groups could be over- or underestimated, but prevalence is
roughly constant in most of the countries with Demographic
and Health Surveys (DHS).)
The effects of ARV treatment are accounted for by removing
the fraction of infected individuals that are alive due to treat-
ment from the prevalence data in each survey.9 To do this, data
on the scale-up of treatment in each country are used, and it is
assumed that treatment is typically initiated 1 year before
expected AIDS death10 and that the age/sex distribution of those
on treatment is approximated by the distribution of AIDS
deaths projected using Spectrum and published HIV prevalence
trend data.4
These estimates of incidence are associated with uncertainty
arising from the sampling error in the prevalence estimates.
Further, in the countries with smaller epidemics, household
surveys could underestimate the true HIV prevalence, given the
concentration of infection in populations that are not fully
captured (eg, hostels, brothels, military/police barracks).11 In all
settings, non-response could also lead to underestimation of
prevalence, although we expect this effect to be small,11e13 and
if it is constant over age and time, the estimated age distribution
will be reliable. The method also does not account for the
possibility of different rates of international migration by HIV
status and age, which could introduce bias. Such information on
international migration by HIV status is not available, but
experimentation with the method suggests that the magnitude
of any errors introduced by migration is likely to be small.
We applied this method to data on HIV prevalence by age and
sex from 28 DHS and AIDS Indicator Surveys. Four countries
had more than one survey (Dominican Republic, Kenya, Mali
and Zambia). For countries with adult prevalence above 4% the
sample sizes are large enough for the incidence patterns to be
relatively smooth. Figure 2 shows the resulting patterns for
males and females. For countries with lower prevalence the
patterns are more scattered. We calculated average patterns for
these two sets of countries and also calculated a pattern for the
injecting-drug user (IDU)-driven epidemics of Eastern Europe
based on new HIV case reports.14 The resulting patterns are
shown in ﬁgure 3.
The same analysis indicates that the ratio of female to male
incidence among adults 15e49 varies from 0.5 to 2.4 with
a median of 1.38 in generalised epidemics, 0.84 in low level and
concentrated epidemics, and 0.42 in IDU-driven epidemics. The
ratios vary considerably across countries. This variation is
reﬂected when uncertainty analyses are run.
These patterns are used in Spectrum for all countries in each
epidemic type and are assumed to be constant from the begin-
ning of the epidemic. These assumptions produce a good match
to the survey measures of prevalence by age and sex 20e30 years
after the start of epidemic, as shown in ﬁgure 4.
HIV INFECTION AMONG CHILDREN
Previous versions of Spectrum estimated new HIV infections
among children as occurring around delivery, through the
combined probability of infection in utero, peripartum and
intrapartum, and through breastfeeding. The survival pattern
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Figure 1 Inputs, outputs and process of the demographic and AIDS modules in Spectrum.
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was modelled as the proportion of children infected at birth who
survive to each future age and was based on ﬁtting a double
Weibull curve to longitudinal data.15 The double Weibull curve
was used to account for the ﬁnding that some HIV-infected
children are fast progressors (mostly those infected in utero,
peripatrum and intrapartum), and some are slow progressors
(mostly those infected after birth through breastfeeding).
In the latest version of Spectrum, infections around delivery
are tracked separately from those occurring through breast-
feeding in order to follow fast and slow progressors separately.
The probability of HIV infection at birth for a child born to an
HIV-positive mother is assumed to be 20% in the absence of
prophylaxis, 11% with single-dose Nevirapine, 4% with dual
ARV prophylaxis or 2% with triple ARV prophylaxis or treat-
ment.4 The probability of infection through breastfeeding is
assumed to be 1.5% per month for mixed feeding during the ﬁrst
6 months, 0.75% per month for exclusive feeding during the ﬁrst
6 months, 0.75% per month for months 7 and later, and 0.3%
per month when the mother is on triple therapy.16e20
New survival curves for children infected at birth or through
breastfeeding were constructed using data from 12 sub-Saharan
African clinical trials and cohort studies.21
HIV-infected children were divided into categories of early or
late infection, and non-AIDS mortality was removed to focus on
net AIDS mortality. Double Weibull curves were ﬁtted to each
set of data to determine the pattern of survival. As there was
little follow-up beyond 2.5 years, there is limited information to
inform the survival pattern beyond age 2.5. Therefore, the
survival pattern was extended by assuming that children that
have survived at least 2.5 years would have survival similar to
young adults aged 15e24, with a median survival time of about
20 years.22 The resulting survival curves are shown in ﬁgure 5.
The curves indicate a median survival of 1.1 years for early
infection and 9.4 years for late infection, and 9% survival at
20 years for early infection versus 16% for late infection.
ESTIMATING THE PREVALENCE OF DOUBLE ORPHANHOOD
Spectrum estimates the number of maternal, paternal and
double orphans by parent’s cause of death (AIDS and non-AIDS)
based on methods developed for Africa by Grassly and Timaeus
in 2001.23 The number of new maternal orphans is estimated
from the number of women dying each year, their fertility
history and the age-speciﬁc mortality of their children. Paternal
orphans are calculated in a similar manner using estimates of
men’s fertility. If the deaths of the parents were completely
independent, the probability that a child is a double orphan
would be simply the product of the probability of being
a maternal orphan and the probability of being a paternal
Figure 2 Distribution of new HIV
infections by age for males (left) and
females (right) in high-prevalence
countries. AIS, AIDS Indicators Survey;
DHS, Demographic and Health Surveys;
SBS, Sexual Behaviour Survey.
Figure 3 Patterns of the distribution of new HIV infections by age and
type of epidemic. Conc, low level and concentrated epidemics; F,
female; Gen, generalised epidemics; IDU, injecting-drug-user-driven
epidemics; M, male.
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orphan. However, because the parents usually share socio-
economic and other exposures, their risks of death are correlated
for non-AIDS causes. Moreover, due to the sexual transmission
of HIV, AIDS deaths of fathers and mothers are highly corre-
lated. Therefore, Grassly and Timaeus ﬁtted a regression model
to DHS data from countries in sub-Saharan Africa to estimate
the excess risk of being a double orphan as a function of adult
HIV prevalence and aggregate indicators of marriage patterns.
Since that work was carried out, many more DHS surveys have
become available for countries with severe HIV epidemics and
high adult mortality, necessitating a new analysis.
The new analysis uses orphanhood data from 55 African DHS
conducted in 29 countries, each of which collected data on 8000
to 33 000 children. This database does not represent a random
sample of African countries or of points in time. Nevertheless,
the surveys cover countries from all parts of the region. The only
populous African country for which no data are available is the
Democratic Republic of Congo.
The new model includes a somewhat simpler set of explana-
tory variables than the earlier regression model, requiring only
children’s age (a) and adult HIV prevalence (P) at two points in
time to predict the risk of double orphanhood (l).
lnlt;a ¼ q0 þ q1ln~lt;a þ q2ai þ q3lnPt1 þ q4ailn
Pt1 þ q5lnPt12 þ yk þ ut þ gi
where ~l is the risk of double orphanhood assuming independent
risks of maternal and paternal orphanhood; the subscripts t, a, i
and k refer to dates, ages, individual children and countries
respectively; the q values are coefﬁcients to be estimated; yk and
ut are country-level and survey-level distributions of a random
intercept term (assumed to be normally distributed with vari-
ances s2k and s2t), indicating the degree to which the excess risk of
dual orphanhood varies between countries and over time within
countries; and gi is an individual-level residual that is permitted
to have extra-Poisson variation, u.
The coefﬁcients of the revised model are shown in table 1. The
results of applying this equation are shown in table 2 for a low
prevalence and a high prevalence setting. Teenaged orphans are
about three times more likely to be double orphans than they
Figure 4 Comparison of the age pattern
of prevalence from Spectrum projection
from 1970 (dashed lines) to survey
results (solid lines) in Malawi 2004 (left)
and Swaziland 2006/2007 (right). DHS,
Demographic and Health Surveys.
Figure 5 Proportion of HIV-infected children surviving by time since
infection for children infected around the time of birth (early infection,
solid line) or later through breastfeeding (late infection, dashed line).
Table 1 Parameter estimates for random-intercept Poisson regression
models of the percentage of double orphans among children aged 0e17
using Demographic and Health Survey data from countries in mainland
sub-Saharan Africa with generalised HIV epidemics.
Variable Coefficient SE
Intercept 1.3478 0.1563
ln (percentage of children who
are expected double orphans)
0.7539 0.0283
Children’s age 0.02108 0.0131
ln (HIV prevalence in year t1) 0.1506 0.0540
Children’s age3ln (HIV prevalence
in year t1)
0.007225 0.0050
ln (HIV prevalence in year t12) 0.09887 0.0113
Intercountry variance of the intercept 0.0196 0.0059
Intersurvey variance of the intercept 0.0000 0.0000
Extra-Poisson variation 1.7701 0.2071
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would be if the risks of their two parents dying were indepen-
dent. For younger children, the excess risk is even higher.
Compared with Spectrum’s previous estimates, the revised
model produces higher estimates of numbers of double orphans.
The relative differences are greatest for groups in which numbers
of double orphans are small (young children and populations
with low HIV prevalence) and shrink to about 10% in popula-
tions with severe epidemics. The estimates are now more
precise. Conditional on the accuracy of the estimates of
maternal and paternal orphanhood and HIV prevalence gener-
ated by Spectrum, the regression model will usually predict the
number of double orphans to within 64%.
The validity of the predictions made by this regression model
is contingent on the accuracy of the DHS data on orphans.
However, the effects of under-reporting of double and single
orphans tend to cancel out in the estimation of the coefﬁcients,
and various attempts to assess these data have only found
evidence of small to moderate biases in them.22 Moreover, it is
the estimates of AIDS deaths, and maternal and paternal
orphanhood made from surveillance and survey data on HIV
prevalence that largely determine how many children are esti-
mated to be double orphans, not this regression model.
OTHER ENHANCEMENTS
There are a number of other updates to Spectrum for the 2009
estimates. All the demographic inputs have been updated to use
the 2008 round of estimates and projections from the United
National Population Division.5 Procedures for estimating the
number of adults and children eligible for treatment have been
updated based on new analyses of cohort data and can now be
tailored to national eligibility guidelines.24
Survival on ART has also been updated based on the latest
studies for adults and children.25 Estimates of the fertility-
inhibiting effects of HIV infection on fertility have been updated
with analysis of DHS data.26 A new procedure for estimating
ranges for regional and global estimates has been implemented
which uses the same random number streams for global patterns
(eg, progression, treatment effectiveness, prevention of mother-
to-child transmission effectiveness) for each set of Monte Carlo
projections at the country level, allowing the resulting runs to be
summed across regions and the resulting uncertainty ranges
calculated for the combined results. This approach assumes no
correlation across countries in the incidence estimates produced
by EPP, so it may underestimate the true uncertainty.
STRENGTHS
Spectrum is a tool that can be used by national programmes to
estimate key planning indicators using their own data and the
results from international studies. It incorporates the latest
research ﬁndings and is regularly reviewed by the UNAIDS
Reference Group on Estimates, Modelling and Projections.
Modiﬁcations to Spectrum respond to new data availability and
the needs of country programmes.
LIMITATIONS
Many of the assumptions in Spectrum are derived from a small
number of studies that may not be representative of all popu-
lations or all regions. Some estimates of the need for treatment
rely on guidelines as they existed in 2008 and 2009, and ought to
be updated to accommodate the new guidelines for treatment
and PMTCT programmes. Spectrum calculations rely on inci-
dence generated by another model, EPP, so it is important to
ensure that the same assumptions are used in both models. It is
impossible to validate Spectrum estimates for mortality, need for
treatment or orphans for most countries because of a lack of
survey or vital registration data with which to compare.
CONCLUSIONS
Spectrum is one of a package of tools that has been developed to
assist national programmes and international organisations to
estimate the impact of the AIDS epidemic and the needs for
treatment and prophylaxis. It continues to be updated to
incorporate the latest research ﬁndings and provide indicators
needed for programme planning. Recent updates have improved
the estimates, particularly for child infection, treatment need
and double orphans.
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